National Institute of Pharmaceutical Education and Research
2 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
This is a preprint describing a new benchmark and mitigation method for DeFi workflow safety, with controlled testing on held-out prompts but no peer review, external validation, or comparison against published baselines in a clinical or regulatory context.
This is a methods development study with analytical validation and computational toxicity prediction, not a clinical trial or efficacy study; it establishes a detection technique but does not test safety or efficacy in humans.